Yanto Theo Audi, Lugito Nata Pratama Hardjo, Hwei Lie Rebecca Yen, Virliani Cindy, Octavius Gilbert Sterling
Department of Internal Medicine, Universitas Pelita Harapan, Tangerang 15811, Indonesia.
Trop Med Infect Dis. 2022 Nov 9;7(11):361. doi: 10.3390/tropicalmed7110361.
Despite its importance in guiding public health decisions, studies on COVID-19 vaccination acceptance and its determinants in South East Asia (SEA) are lacking. Therefore, this study aims to determine the prevalence of COVID-19 vaccine acceptance and the variables influencing the vaccine's acceptance. This review is registered under PROSPERO CRD42022352198. We included studies that reported vaccination acceptance from all SEA countries, utilising five academic databases (Pubmed, MEDLINE, Cochrane Library, Science Direct, and Google Scholar), three Indonesian databases (the Indonesian Scientific Journal Database, Neliti, and Indonesia One Search), two pre-print databases (MedRxiv and BioRxiv), and two Thailand databases (ThaiJo and Thai-Journal Citation Index). The analysis was conducted using STATA 17.0 with metaprop commands. The prevalence for COVID-19 vaccination acceptance in SEA was 71% (95%CI 69-74; I2 99.87%, PI: 68.6-73.5). Myanmar achieved the highest COVID-19 vaccination acceptance prevalence, with 86% (95%CI 84-89), followed by Vietnam with 82% (95% CI 79-85; I2 99.04%) and Malaysia with 78% (95%CI 72-84; I2 99.88%). None of the ten determinants studied (age, sex, education, previous COVID-19 infections, smoking and marriage status, health insurance, living together, chronic diseases, and healthcare workers) were significantly associated with acceptance. This result will be useful in guiding vaccination uptake in SEA.
尽管其在指导公共卫生决策方面具有重要意义,但东南亚地区关于新冠疫苗接种接受度及其决定因素的研究却很缺乏。因此,本研究旨在确定新冠疫苗接种接受度的流行情况以及影响疫苗接受度的变量。本综述已在国际前瞻性系统评价注册库(PROSPERO)注册,注册号为CRD42022352198。我们纳入了所有东南亚国家报告疫苗接种接受情况的研究,使用了五个学术数据库(PubMed、MEDLINE、Cochrane图书馆、ScienceDirect和谷歌学术)、三个印度尼西亚数据库(印度尼西亚科学期刊数据库、Neliti和印度尼西亚一站式搜索)、两个预印本数据库(MedRxiv和BioRxiv)以及两个泰国数据库(ThaiJo和泰国期刊引文索引)。分析使用STATA 17.0软件的metaprop命令进行。东南亚地区新冠疫苗接种接受度的患病率为71%(95%置信区间69 - 74;I² 99.87%,预测区间:68.6 - 73.5)。缅甸的新冠疫苗接种接受度患病率最高,为86%(95%置信区间84 - 89),其次是越南,为82%(95%置信区间79 - 85;I² 99.04%),马来西亚为78%(95%置信区间72 - 84;I² 99.88%)。所研究的十个决定因素(年龄、性别、教育程度、既往新冠病毒感染史、吸烟和婚姻状况、健康保险、共同居住情况、慢性病以及医护人员)均与疫苗接受度无显著关联。这一结果将有助于指导东南亚地区的疫苗接种工作。